United States Antimony Corp. Faces Reporting Controversy While Advancing Critical‑Mineral Processing

Inaccurate Reuters Story Sparks Investor Scrutiny

On 29 January 2026, a news release issued by the company’s own access‑Newswire team highlighted an article published by Reuters that the company described as “inaccurate and misleading.” The piece, dated the same day and labeled United States Antimony Corp.: Inaccurate and Misleading Reuters Article, was issued from Dallas, Texas. The company, listed on NYSE American under the ticker UAMY and also on NYSE Texas, issued the statement to clarify that the Reuters coverage failed to accurately portray its operations and market position. While the exact details of the misstatement were not disclosed, the company’s response underscores its commitment to transparent communication with shareholders and market participants.

Hydromet Processing Breakthrough for Critical Minerals

Two separate press releases dated 28 January 2026 announced a significant technological advancement by United States Antimony Corp. The company revealed progress in hydromet processing aimed at enhancing the extraction and refinement of critical minerals, namely antimony, cobalt, tungsten, and zeolite. These releases, titled United States Antimony Corporation Announces New Hydromet Processing Advancement for Critical Minerals, were disseminated through ACCESS Newswire from Dallas, Texas. The company, which already specializes in the refinement, production, and sale of antimony metal, antimony oxides, and sodium antimonate, has extended its expertise to include the mining, milling, and concentration of silver and gold‑bearing rock, as well as a joint venture focused on zeolite mining and distribution. The hydromet development is expected to improve yield and reduce processing costs, positioning the firm as a more competitive player in the global critical‑minerals market.

Company Profile and Market Snapshot

United States Antimony Corp. is headquartered in Thompson Falls and operates primarily in the Materials sector, specifically within Metals & Mining. The company’s asset profile is summarized as follows:

  • Primary Exchange: NYSE American
  • Currency: USD
  • Close Price (29 Jan 2026): $7.33
  • 52‑Week High (13 Oct 2025): $19.71
  • 52‑Week Low (3 Mar 2025): $1.21
  • Market Capitalization: $1.026 460 928

The stock’s recent performance reflects broader volatility in the U.S. equity markets, which experienced downward pressure on major indices such as the S&P 500 and Nasdaq. Market commentators noted that high‑profile tech earnings and heightened artificial‑intelligence spending were key factors driving investor sentiment that day, contributing to a broader sell‑off in technology and growth stocks.

Strategic Implications

The company’s dual focus—addressing misinformation in the media while pursuing technical innovation—demonstrates a proactive strategy to safeguard its reputation and enhance operational efficiency. The hydromet breakthrough aligns with global demand for reliable supplies of critical minerals, an area that has garnered increased attention from both industry and policy circles. Moreover, the company’s diversified product portfolio—including antimony derivatives and precious‑metal concentrates—provides multiple revenue streams that may help buffer against price swings in any single commodity.

Outlook

With the newly announced processing advancements and a clear stance on media accuracy, United States Antimony Corp. is positioned to strengthen its standing in the critical‑minerals sector. Investors will likely monitor the company’s subsequent earnings reports and operational updates for further evidence of how these developments translate into financial performance and market share gains.